Laura Vallés Saiz

I am a biotech scientist and entrepreneur, CEO and co-founder of ELE Biotech, a Spanish deep-tech startup developing an accessible molecular test for early screening of Alzheimer’s disease and other tauopathies, paired with AI-driven software for dynamic risk stratification. My mission is to integrate early dementia detection into routine clinical pathways, giving patients more time and options.

I hold a PhD in Molecular Biosciences and have experience in biomarkers, cellular aging and neurodegeneration. I lead the development of ELE Biotech’s technology, which is protected by an international patent.

We are now entering multicenter clinical validation and preparing for international expansion, with growing interest from clinicians, laboratories, philanthropic organizations and investors focused on health and longevity.